Introduction {#S0001}
============

Nanomaterials have a wide range of applications in biomedical sciences, such as in therapeutic agents, diagnostic imaging systems, and drug delivery systems.1,[@CIT0002] Cockle-shell-derived aragonite nanoparticles (NPs) have been reported as excellent and promising materials for therapeutics and antibiotic-loaded implants.[@CIT0003],[@CIT0004] It was reported that calcium carbonate (CaCO~3~) NPs have great potential efficient drug delivery systems. With biocompatibility and pH-sensitive properties[@CIT0005] the anticancer drug doxorubicin (DOX) suggests its promising effects as a therapeutic agent in the clinical treatment of tumors.[@CIT0006],[@CIT0007] It has been shown in an earlier study that CaCO~3-~DOX NPs have higher toxic effects on cancer cells compared to DOX alone.[@CIT0008] The DOX/nanocrystals approach is vital for the enhancement of cancer therapy owing to the biodegradability, safety, and pH sensitivity of the system[@CIT0009] Furthermore, biobased aragonite CaCO~3~-NPs have received vast attention amongst numerous researchers as a potential drug release agent.[@CIT0005],[@CIT0010],[@CIT0011] In the recent utilization of CaCO~3~-based NPs, spherical NPs have been designed as a novel delivery carrier for drugs and bioactive proteins, demonstrating sustained release in addition to high stability.[@CIT0005],[@CIT0012] The present study focuses on the synthesis of cockle-shell-derived CaCO~3-~NPs loaded with DOX as, a nano-anticancer carrier. The drug-loading capacity, encapsulation efficiency, and in vitro release profile of DOX-loaded CaCO~3-~NPs were evaluated. The synthesized CaCO~3~-NPs loaded with DOX were additionally evaluated for therapeutic efficacy against human breast cancer cells in vitro. CaCO~3~ NPs with specific shape and sizes are very useful in biomedical applications[@CIT0013] These NPs have been reported as carriers with capabilities of retaining encapsulated drugs and bioactive proteins for sustained release at targeted cancer cells.[@CIT0014] As a result, there is an increasing demand for the assembly of NPs with different morphologies, shapes, and sizes for various specialized areas.[@CIT0015] Different methods of preparing CaCO~3-~NPs have thus been reported for the delivery of soluble and insoluble drugs and bioactive proteins.[@CIT0016] The increasing need for these nanocrystals for drug delivery should be met with improved techniques that enhance homogeneity to an optimal grade.[@CIT0010],[@CIT0017] In this regard, the present study developed a simple, environmentally friendly method of cleaning cockle shells with banana pelt agent, followed by mechanical grinding and simple precipitation. This reproducible procedure enabled the synthesis of highly homogenized spherical nanocrystals.

Materials and methods {#S0002}
=====================

Materials {#S0002-S2001}
---------

Cockle shells were purchased from a local Malaysian market. Dodecyl dimethyl betaine (BS-12) was purchased from Sigma-Aldrich (USA). Doxorubicin hydrochloride (DOX) was obtained from EMD Millipore Corporation (USA). PBS was acquired from (Sigma Aldrich St. Louis, MO, USA). All supplementary reagents were of analytical grade and used without modification unless stated otherwise in the experiment.

Preparation of micro-sized CaCO~3~ powder from cockle shells {#S0002-S2002}
------------------------------------------------------------

Cockle shells (*Anadara granosa*) were washed with tap water. The shells were then boiled for 30 min in a steel container and oven-dried (Member UM 5000, Germany) at 60°C. The dried shells were further washed in 100 mL of water containing squeezed banana pelt agent ([Figure 1](#F0001){ref-type="fig"}) at a ratio of 2:1 to remove stains and remaining debris on the cockle shells. The cockle shells were ground into powder form using a rotary pulverizing blending machine (RT-08 rpm 2500) and sieved at a pore aperture of 75 µm. The prepared cockle shell--based CaCO~3~ powder was stored in a drying oven at 50°C before further analysis.Figure 1Molecular structure of banana peel.

Synthesis of nano-sized CaCO~3~ from cockle shell-aragonite powder {#S0002-S2003}
------------------------------------------------------------------

Approximately 2 g of CaCO~3~ powder with a size of 75 µm was added to 50 mL of deionized water. Then, 0.5 mL of BS-12 was added to the aqueous solution in a flat-bottom flask, and the solution was stirred at 1,000 rpm at 27°C for 2 hrs. After cooling, the aqueous solution was filtered with filter paper using deionized water and sediment NPs were allowed to dry in an oven for three days at 50°C.

Preparation of DOX-loaded CaCO~3~-NPs (DOX-NPs) {#S0002-S2004}
-----------------------------------------------

One milligram of the DOX was added to 15 mg of CaCO~3~NPs suspension. The suspension was persistently stirred overnight in a dark room at 25°C. CaCO~3~NPs containing DOX were centrifuged (Eppendorf, Centrifuge 5702 R, Germany) at 120 rpm, washed, and oven-dried at 25°C.

The following parameters were calculated; $$\documentclass[12pt]{minimal}
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The mathematical equations were adapted from a previous report.[@CIT0017]

Characterization of CaCO~3-~NPs and DOX- NPs {#S0002-S2005}
--------------------------------------------

### Morphology and surface charge of CaCO~3~-NPs and DOX-NPs {#S0002-S2005-S3001}

The physicochemical properties of the NPs were then analyzed by high-resolution transmission electron microscopy (HRTEM: H-7100 Hitachi, Tokyo, Japan) at a voltage of 5 kV and field-emission scanning electron microscopy (FESEM, JOEL JSM-7600F, USA) at 200 kV and 30 mA. The CaCO~3~ NPs and DOX-NPs were dissolved in 90% ethanol and sonicated for 30 mins. From each suspension, one drop was loaded on top of a carbon-coated copper grid and dried at room temperature prior to viewing with TEM.[@CIT0018] For FESEM, the samples were separately equipped on aluminum and coated with gold under an argon atmosphere by means of sputter coating measure using a Malvern Zeta-sized Nano ZS (Ver. 6.12, Serial no: MAL 1,042,820, Malvern Instruments). This measures the electrophoretic mobility of particles in an electrical field and then converts it into zeta potential.

### Fourier-transform infrared spectroscopy (FT-IR) {#S0002-S2005-S3002}

FT-IR spectroscopy (Model 100 series, Perkin Elmer) was used to analyze the chemical properties of the CaCO~3~ NPs, NPs, DOX-NPs, and free DOX and the absorption spectra of CaCO~3~ 280--4000 cm^−1^ at a motion of 2 cm ^--\ 1^ and speed of 64 scan per second.

X-ray powder diffraction (XRD) {#S0002-S2006}
------------------------------

The purity and crystalline properties of NPs alone, DOX-NPs, and free DOX powders were examined using a Rigaku XRD. Traverse sections of the specimen were placed on a quartz plate for exposure to Cu Kα radiation wavelength of λ=1.5406 Ã. The samples were scanned at diffraction angles from 2° to 80° to obtain unique patterns of reflection peaks, at different angles and intensities at room temperature, over 2Ө ranges of 4--50°, and at sampling intervals 2θ=0.02° at a scanning rate of 0.6°/min.

### In vitro drug release study {#S0002-S2006-S3001}

To evaluate the mechanism of synthesized NPs, the release profiles of DOX-NPs were examined in PBS solutions at pH 7.4 and 4 DOX-NPs were detached inside the aqueous buffer solution (1 mg/mL) and transferred to a dialysis membrane bag (molecular weight cutoff =10 kDa). The release experiment was initiated by placing the dialysis bag in 10 mL of discharge media. The media were shaking in (TU-400) at 37°C 100 rpm. At predetermined time intervals (0, 0.5, 2, 3, 6, 12, 24, 48, and 72 hrs), the samples were evaluated using ultraviolet visible spectrophotometry to quantify the concentration of DOX release.

### Cell culture {#S0002-S2006-S3002}

The human breast cancer cell line (MCF-7) was selected for this study. MCF-7 was purchased commercially from the American Type Culture Collection (ATCC, Manassas, VA, USA). The cell line was cultured in high-glucose Dulbecco's modified Eagle medium containing 10% fetal bovine serum and 100 µg/mL penicillin and streptomycin at 37°C in 5% CO~2~ incubator (Thermo Fisher Scientific, USA).

### Cell line viability assay {#S0002-S2006-S3003}

The cells were seeded in 96-well plates (MCF-7 at 1×10^4^ cells/well) and incubated for 24 hrs. To evaluate the biocompatibility of free NPs, MCF-7 cells were co-cultured with different concentrations of NPs for 24 hrs. For the cytotoxicity assay of DOX-NPs, MCF-7 cells were treated with different concentrations of DOX and DOX-NPs, for 24, 48, and 72 hrs. The NPs were sterilized with UV irradiation for 30 mins before use. Untreated cells served as the controls and nine wells without cells were used as blank controls. Subsequent to the exposure, the cells were washed with PBS, and MTT reagent (5 mg/mL) was added and incubated at 37ºC for 4 hrs. The culture medium was discarded, and 200 μL of freshly prepared dimethyl sulfoxide was added to dissolve the formazan dye crystals into purple color. The absorbance was measured at 570 nm using a spectrophotometer microplate reader. Each assay was performed in triplicates. An IC~50~ standard, which signifies the drug concentration that inhibits 50% of the tested cells, acts as an indication of cell viability and was computed using the following equation: $$\documentclass[12pt]{minimal}
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where A test is the optical density of cells incubated with different treatments along and A control is the optical density of cells incubated with culture media only (negative control). The cytotoxicity was calculated from an average of three replicate tests and the results are expressed as mean ± standard deviation.

### Apoptosis evaluation {#S0002-S2006-S3004}

Apoptosis of cells treated with DOX and DOX-NPs was evaluated by measuring the intrinsic fluorescence of DOX. MCF-7 cells were seeded in 6-well plates at a density of 5×10^5^ cells/well. After 48 hrs of incubation, the medium was discarded and replaced with fresh medium, containing DOX or DOX-NPs with a corresponding DOX concentration of 0.5 µg/mL for 48 and 72 hrs at 37°C Acridine orange and propidium iodide were added into the culture medium to label control, apoptotic, and necrotic cells and then 1 mL of cells in the medium was transfer to a 15-mL tube after trypsinization. The cells were fixed, re-suspended in cold PBS, washed, and mounted on microscope slides. Fluorescence was visualized on fluorescence using a microscope (Nikon ELIPSE Ti S, Japan).

### Ultrastructural microscopy of treated MCF-7 cells {#S0002-S2006-S3005}

The IC~50\ values~ of DOX and DOX-NPs were used to induce apoptosis in MCF-7 cells. The cells were co-cultured with the NPs for 48 hrs. They were then trypsinized, centrifuged for 10 mins at 2000 rpm, and fixed in 4% glutaraldehyde for 24 hrs at 4ºC. The immobile cells were rinsed three times with of sodium coccadylate buffer for 10 mins each and post-fixed with 1% osmium tetroxide at 4°C for 2 hrs. Thereafter, the cells were dehydrated using acetone (35%, 50%, 75%, and 100%) and critical point dried CO~2~ using a critical point-drier (CPD 030, Bal-TEC, Switzerland) for 30 mins. The cells were fixed on a metal SEM stub sputter coated in gold using the SEM coating unit (E5100 Polaron, UK). The coated samples were examined using SEM (JOEL 6400, Japan).

For TEM, the cells were seeded in 6-well plates at 5×10^5^cells/well in 2 mL of complete growth medium, incubated for 24 hrs and treated with the IC~50~ of DOX (0.5 µg/mL) and DOX-NPs (with corresponding DOX concentration) for 48 hrs. Control cells were treated with complete growth medium only. After 48 hrs of incubation, the cells were rinsed with PBS and harvested. Subsequently, the cells were fixed with 4% glutaraldehyde for 24 hrs at 4°C and post-fixed with 1% osmium tetroxide at 4ºC for 2 hrs. Subsequent to each fixing, the cells were rinsed three times with 0.1 M sodium coccadylate buffer. Then, the cells were dehydrated with increasing concentrations of acetone (35%, 50%, 75%, 95%, and 100%). The cells were infiltrated with resin and embedded with 100% resin in beam capsule and then left to polymerize at 60ºC for 48 hrs. Thereafter, the selected area was cut into ultrathin sections using an ultra-microtome, placed onto copper grids, and stained with uranyl acetate and citrate. The stained samples were viewed using HRTEM (HRTEM: H-7100 Hitachi, Tokyo, Japan).

Statistical analysis {#S0002-S2007}
--------------------

Statistical analysis was conducted using triplicate samples. The results are expressed as mean ± standard deviation and plotted in columnar graphs using the Origin 8.5 software (Origin Lab, MA, USA).

Results {#S0003}
=======

Morphology and surface charge of CaCO~3-~NPs and DOX-NPs {#S0003-S2001}
--------------------------------------------------------

The morphology of the NPs before and after drug-loading displayed a homogeneous spherical shape, with a distributed size of 35.5 nm, under TEM ([Figure 2](#F0002){ref-type="fig"}). The image shows a porous characteristic in support of the synthesized NPs. FESEM before and after drug loading into the NPs depicted spherical shapes with an average diameter of 29.7±5 nm is shown in in [Figure 3](#F0003){ref-type="fig"}.Figure 2HRTEM morphology of NPs (**A**) before and (**B**) after drug loading on NPs.**Abbreviations:** HRTEM, high-resolution transmission electron microscopy; NPs, nanoparticles.Figure 3Field-emission scanning electron microscopy morphologies of nanoparticles (**A**) before and (**B**) after drug loading.

The zeta potential analysis shows the surface potential of −19.1±3.9 mV and avergae diameter of 167.2 nm of the NPs, respectively, at an average temperature of 24.0°C with a polydispersity index of 0.237 and 100% intensity as revealed in [Figure 4](#F0004){ref-type="fig"}. The zeta potential of -- 17.8±4.6 mV of the loaded DOX-NPs is shown in [Figure 4](#F0004){ref-type="fig"}.Figure 4Zeta potential representations (**A**) showed the distribution of nanoparticles (NPs) derived from cockleshells, (**B**) doxorubicin NPs, and (**C**) zeta size representations.

FT-IR analysis {#S0003-S2002}
--------------

The FT-IR spectra of NPs, DOX-NPs, and DOX are presented in [Figure 5](#F0005){ref-type="fig"} at 1478, 1082, 860, and 712 cm^--1^, respectively. The FT-IR spectra of DOX shows the presence of hydroxide (OH^−^) and amino (-NH~2~) functional groups. The absorption peak at 2931 cm^--1^ was attributed to the --NH~2~ cluster of DOX, which overlapped with the broad band of OH^--^ as depicted in the structure of DOX. The presence of the distinctive peaks of DOX shows efficient loading of the drug into the NPs, as indicated in [Figure 5](#F0005){ref-type="fig"}.Figure 5FT-IR and XRD patterns of NPs, DOX-NPs, and DOX.**Abbreviations:** DOX, doxorubicin; NPs, nanoparticles; FT-IR, *Fourier-transform infrared spectroscopy*; XRD, x-*ray powder diffraction*.

XRD analysis {#S0003-S2003}
------------

The XRD patterns of the CaCO~3-~NPs, DOX, and DOX-NPs are shown in [Figure 5](#F0005){ref-type="fig"}. The XRD pattern of NPs was similar to the aragonite reference spectra in the Inorganic Crystal Database (ICSD) file no. 98-010-9084. In the same regard, the XRD pattern of DOX-NPs was comparable to that of the NPs. This indicates that the unique crystal nature of aragonite was not altered by drug loading.

Drug loading {#S0003-S2004}
------------

DOX was loaded in NPs at different ratios. As revealed in [Table 1](#T0001){ref-type="table"}, with increasing loading concentrations of DOX (1, 2, and 3 mg), higher loading contents were observed (6.25%, 12.9%, and 19.3%, respectively) while the loading efficiencies of the three formulations increased from 93.8% to 97%.Table 1Drug loading concentrations, drug content, and encapsulation efficiency of doxorubicin nanoparticles (DOX-NPs)SampleWeight of nanoparticles (mg)Weight of drug (DOX) (mg)Loading content (%)Encapsulation efficiency (%)DOX-NP (1)1516.2593.8DOX-NP (2)15212.997.0DOX-NP (3)15319.396.7

In vitro DOX release profile {#S0003-S2005}
----------------------------

As presented in [Figure 6](#F0006){ref-type="fig"}, the in vitro drug discharge profile of DOX from DOX-NPs (drug-loaded delivery-carrier in the first stage) simulated physiological conditions with excellent pH sensitivity (˂36% pH 7.4). An extremely small amount of DOX was released in PBS at 70% gradually and sustainably within 72 hrs. More importantly, when DOX was exposed to an acidic environment at pH 4.8, sustainable release. Approximately 73% of the DOX was released speedily within 1 hr, and within a long period of 72 hrs, almost 74% of the total DOX was released at pH 4.8. In basic pH, 32% of DOX was released from CaCO~3-~NPs within 2.5 hrs, and with increasing time, approximately 70% of DOX was released gradually within 4 hrs.Figure 6The in vitro drug release profile of DOX from doxorubicin nanoparticles (DOX-NPs) cell culture.

Morphological examinations {#S0003-S2006}
--------------------------

Inverted light microscopic images of MCF-7 cells were treated for 48 hrs with DOX and DOX-NPs. (A) Control cells (100X). (B) Cells treated with free NPs (100X). (C) Cells treated with free DOX (100X). (D) Cells treated with Dox-NPs (100X). Red arrows depict Cell shrinkage and detachment; yellow arrows depict DOX-NP Coacervates in [Figure 7](#F0007){ref-type="fig"}.Figure 7Morphology of MCF-7 cells treated for 48 hrs with DOX as well as doxorubicin nanoparticles (DOX-NPs). (**A**) Control cells (untreated). (**B**) Cells treated with free NPs. (**C**) Cells treated with DOX. (**D**) Cells treated with DOX-NPs. Red indicators portray cell shrinkage with detachment; yellow arrows portray DOX-NPs coacervates (scale bar: 100 µm).

MTT cytotoxicity assay for DOX and DOX-NPs {#S0003-S2007}
------------------------------------------

The cytotoxicity of DOX and DOX-encapsulated CaCO~3~-NPs was investigated using MCF-7 cells via the MTT assay. MCF-7 cells were treated with different concentrations of DOX and DOX-NPs and incubated for 24, 48, and 72 hrs. The cell inhibition rate was dependent on the drug concentration and incubation period, as shown in [Figure 8](#F0008){ref-type="fig"}. MCF-7 cells were more susceptible to DOX than they were to DOX-NPs for 24 hrs and 48 hrs, while at 72 hrs, they were more sensitive to DOX-NPs than they were to free DOX.Figure 8Cytotoxicity of DOX and doxorubicin nanoparticles (DOX-NPs) on MCF-7 cells with the IC~50~ for DOX-NPs and DOX at 24, 48, and 72 hrs, respectively. The means with asterisk (٭) differed significantly (*p*˂ 0.05) with the normal untreated group (\#).

Biocompatibility assay for cockle shell-aragonite CaCO~3~ nanocrystals {#S0003-S2008}
----------------------------------------------------------------------

The effect of cockle-shells derived CaCO~3~ nanocrystals on MCF-7 cells was evaluated to verify the toxicity of the carrier for compatibility studies in the biological scheme ([Figure 9](#F0009){ref-type="fig"}). The MTT assay is based on the principle where mitochondrial oxidoreductase (NADP pH-dependent) enzymes convert the water-soluble yellow MTT tetrazolium dye into the insoluble purple formazan via cleavage of the tetrazolium ring. The formazan product is resistant to cell membranes with loss of integrity and consequently only accumulates inside healthy cells.Figure 9Biocompatibility of cockle shell--derived CaCO~3~ nanoparticle (NP) on MCF-7 cells.

The analyzed results showed good biocompatibility of cockle shell CaCO~3~ NPs and indicated zero apparent toxicity toward MCF-7 cells with greater than 92% cell viability, even at high concentrations of 800−1000 µg/mL.

Acridine orange and propidium iodide double staining is an excellent method of measuring the cell viability precisely as the dyes are permeable to both live and dead cells, enabling necrotic and apoptotic cell death to be distinguished. As demonstrated in [Figure 10](#F0010){ref-type="fig"}, healthy cells have round nuclei along with green staining, whereas apoptotic cells are stained red as a results cell blebbing and fragmented DNA is shown in orange.Figure 10Fluorescent microscopy images of MCF-7 cells at 48 hrs stained by acridine orange and propidium iodide (AO/PI) (**A**) control MCF-7 cells (untreated), (**B**) treated with DOX, and (**C**) treated with doxorubicin nanoparticles (DOX-NPs). Scale bar: 100 µm.

Ultrastructural surface morphology of treated MCF-7 cells {#S0003-S2009}
---------------------------------------------------------

SEM was performed to acquire detailed evidence of the ultrastructural surface alterations of MCF-7 cells upon treatment with DOX-NPs for 48 hrs at IC~50.~ The untreated cells revealed typical morphological structures of cancer cells, with numerous lamellipodia and microvilli on the surface ([Figure 11](#F0011){ref-type="fig"}[A](#F0011){ref-type="fig"}). Morphological alterations on the lamellipodia and microvilli were observed in the treatment groups ([Figure 11B](#F0011){ref-type="fig"} and [C](#F0011){ref-type="fig"}). Cells treated with DOX demonstrated a decrease in the quantity of microvilli along with observable deformation, even though the cells treated with DOX-NPs demonstrated a relatively polished surface with disappearing microvilli. Furthermore, in the treatment groups, separate apoptotic bodies, irregular plasma membranes, and cell shrinkage were evident. Cell shrinkage is a typical feature of early apoptosis and has been correlated with nuclear and cytoplasm manifestations of apoptosis ([Figure 11](#F0011){ref-type="fig"}).Figure 11SEM micrographs of surface ultrastructural features. (**A**) Untreated MCF-7 cells. (**B**) MCF-7 cells treated with DOX exhibiting membrane blebbing, cell shrinkage with apoptotic body. (**C**) MCF-7 cells treated with CaCO~3~NP-DOX exhibiting membrane blebbing, Cell shrinkage (25,000)×, bar 10 µm.**Abbreviations:** DOX, doxorubicin; NPs, nanoparticles; SEM, scanning electron microscopy.

Morphology of treated MCF-7 cells {#S0003-S2010}
---------------------------------

The difference in cell morphology was examined to perceive the effect of DOX and DOX-NPs on MCF-7 cells via TEM. The ultrastructural features of MCF-7 cells are exhibited in [Figure 12](#F0012){ref-type="fig"} by electron micrographs. The micrographs of untreated cells and cockle shell NPs demonstrated well-distributed chromatin, clear nuclear membranes, and exposed cell organelles with complete integrity ([Figure 12A](#F0012){ref-type="fig"}). Notable alterations after treatment with DOX or DOX-NPs were demonstrated with typical apoptotic phenomena ([Figure 12C](#F0012){ref-type="fig"}), with signs of early apoptosis such as chromatin condensation, cell shrinkage, and margination in both treatment groups. An enormous number of vesicles were present in the cytoplasm, and a small number of vacuoles containing DOX-NP coacervates were observed ([Figure 12D](#F0012){ref-type="fig"}). These designated DOX-NPs were able to internalize into cells. However, similar alterations were observed in [Figure 12D](#F0012){ref-type="fig"}.Figure 12Electron micrographs of MCF-7 cells (**A**), control untreated cells and (**B**) treated with NPs exhibiting normal cellular method containing unabridged integrity of cells organelle, with rounded shaped cells containing nucleus and nucleolus chromatin (orange arrow) (**C**) Treated with DOX with switch nuclear collapse, progressing blebbing, apoptotic body formation (yellow arrow), and (**D**) treated with NP-DOX revealing chromatin condensation, bar 2 µm.**Abbreviations:** DOX, doxorubicin; NPs, nanoparticles.

Discussion {#S0004}
==========

This study reports the development of doxorubicin-based aragonite NPs for the treatment of MCF7 luminal cell line. It highlights the cheap synthesis of cockle-shell derived CaCO~3~-NPs under a mild and environmentally friendly condition and its effectiveness as a nano-carrier in cancer therapy. DOX is a potent chemotherapeutic agent used in the management of different cancer patients[@CIT0019] However, its off-target effect poses a potential threat to the patient due to induced cardiotoxicity. This has prompted the search for synthetic inorganic carriers with targeting ability to deliver DOX as a new strategy to ameliorate the off-target effects.[@CIT0020]

As a remedy to the toxic effect of DOX, the potential of CaCO~3~NPs loaded with DOX in breast cancer therapy is explored. The purity of the NPs was fortified by the use of banana pelt, instead of conventional bleaching agents as a means of cleansing the cockle shells of inherent dirt. This helped forestall reactivity and attendant impurity. Calcium carbonates are naturally abundant in the form of aragonite polymorph in seawater organisms.[@CIT0021] The physicochemical properties of the synthesized CaCO~3~-NPs are essential in drug delivery, which consequently improves therapeutic safety and efficacy.

In this study, the pleomorphic geometry of CaCO~3~NPs after being loaded with DOX remained the same with more dispersed particles with a diameter of less than 40 nm. This geometry was similar to that reported in a previous study, where the toxicity and effectiveness of DOX were improved upon the use of nanomaterials of this nature.[@CIT0022] The negative zeta potential and shape of the DOX-CaCO~3~ NPs might have induced the increased loading content and targeting potential in the treatment of cancers cells.[@CIT0005]

Based on the FT-IR spectra, the peaks were comparable to published reports[@CIT0010],[@CIT0016],[@CIT0023],[@CIT0024] that utilized CaCO~3~ nanocrystals for drug delivery and tissue engineering.

The spectral peaks observed on DOX-NPs indicate clear signature of both DOX and aragonite CaCO~3~NPs as cited earlier,[@CIT0017] with DOX showing signatory spectra at 3513 and 3327 cm. The presence of these spectra peaks strongly indicates the successful loading of DOX in the CaCO~3~NPs. However, there were slight shifts in the spectra at 708 cm^−1^, 1442 cm^−1^, 1089 cm^−1^, and 858 cm^−1^, which might be due to the binding between the drug and the CaCO~3~NPs. Moreover, the peaks of the functional groups were retained as seen in previous works whereby nano-encapsulation strategies were used to deliver DOX.[@CIT0025],[@CIT0026] However, some new functional group peaks have emerged in these works.

The acquired diffraction spectra were similar to the conventional reference spectra of CaCO~3~ (ICSD No 98-010-9084). In addition, the XRD spectra of CaCO~3~ were similar to those that were synthesized using different methods.[@CIT0004],[@CIT0027],[@CIT0028]

DOX was successfully loaded in the CaCO~3~NPs, thus showing the high potential of these NPs as effective delivery vehicles for anticancer drugs. Minimal losses were demonstrated during the drug-loading process and these were attributed to the negative surface charge of electrostatic interactions. DOX-NPs were found to have more elevated loading content at 19.3% and were thus chosen for drug delivery.

Our drug release results agree with those in previous studies utilizing different NP droplets as delivery vehicles for DOX. In these studies, the peak DOX release was observed after 3 hrs with sustained release of DOX in a slow manner in the medium at physiological pH. This was similar to the previous reports,[@CIT0017],[@CIT0028] indicating enhanced bioavailability.

Additionally, previous literature has reported that the higher cytotoxicity of drugs formulated into NPs could be ascribed to the combination of diverse but not exclusive mechanisms. The formulated particles were absorbed through the cell surface, resulting in increased drug concentration in the cell membrane, which in turn generates viability and a concentration gradient that aids in the influx of the drug into the cell.[@CIT0029] DOX is delivered into the cell cytoplasm via the process of passive diffusion. On the other hand, CaCO~3-~NPs are taken up by cells through endocytosis, which results in the increased cytotoxicity DOX-loaded NPs, allowing it to bypass ejection from cell by P-gp pumps.[@CIT0018]

However, Kamba et al (2013) reported lower cell viability, following treatment of cells with 2 μg/mL DOX for two days; verifies the sustained release of DOX from the multilayer NPs. These differences in cytotoxicity are explained by many scholars as a result of the effects of DOX on cell viability.[@CIT0030] Free DOX is mediated through a passive diffusion mechanism and thereby directly affects normal cells, whereas in the case of DOX-NPs, the DOX is released in a time-dependent manner from the CaCO~3~ NPs before it exerts its effects on the cells.

The size, shape, and zeta potential of nano-carriers are likely to induce apoptosis as observed in similar inorganic NPs[@CIT0029] As an NPs drug delivery vehicle, CaCO~3~ was demonstrated to be biocompatible and non-toxic. This finding is in line with previous reports,[@CIT0012],[@CIT0018] where CaCO~3~NPs showed good cytocompatibility with MG 63 cells. Therefore, the application of CaCO~3~ in recent years has advanced beyond drug delivery. Significant research effort is being devoted to the development of effective cancer therapy in biomedical applications.[@CIT0031]

Our treatments resulted in different morphological modifications, which are typical features of apoptosis.[@CIT0032],[@CIT0033] These results provide proof that DOX-NPs can induce apoptosis in MCF-7 cells.

The characteristic features and ultrastructural alterations in MCF-7 cells were observed by SEM. Cell shrinkage is the most characteristic feature of early apoptosis.[@CIT0034] Membrane blebbing is one of a sequence of typical morphological measures during apoptosis.[@CIT0034] Apoptosis yields cell fragments called apoptotic bodies, the presence of which suggests that cells are in the late phase of apoptosis. Our treatments resulted in separate morphological modifications that are typical features of apoptosis.[@CIT0035] The most important signs of early apoptosis are cell shrinkage, margination, and chromatin condensation, which were observed in both treatment groups.[@CIT0034] Characteristic apoptotic phenomena, including membrane blebbing and apoptotic bodies, were also observed, showing that DOX-NPs were able to induce apoptosis in breast cancer cells.

The method used in this study employs a simple synthesis technique with a slight modification that avoided the involvement of stringent temperatures and monotonous gas frothing. Normally, high drug-loading ability is vital in achieving desirable drug efficacy for long-term drug carriers and this has been achieved. In addition, the CaCO~3~NPs showed good biocompatibility with cells. Following DOX loading, DOX-NPs displayed pH-sensitive drug release properties. However, to the best of our knowledge, data on the use of banana pelts is on record for the treatment of cockle shells used in the synthesis of NPs.
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